Sumitomo Mitsui Trust Group
GHDX

Sumitomo Mitsui Trust Group’s Genomic Health, Inc. GHDX Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,761
Closed -$544K – 1043
2019
Q1 		$544K Sell
7,761
-2,690
-26% -$199K ﹤0.01% 895
2018
Q4 		$665K Buy
+10,451
New +$733K ﹤0.01% 849

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group's GHDX Position: Q2 2019 in Review

Sumitomo Mitsui Trust Group sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 7,761 shares — an estimated $544K sold.

Sumitomo Mitsui Trust Group first reported a position in GHDX in Q4 2018 and held it in 2 quarters. The position peaked at $665K in Q4 2018. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

  • Sumitomo Mitsui Trust Group reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 7,761 Genomic Health, Inc. shares in Q2 2019, an estimated $544K.
  • Sumitomo Mitsui Trust Group first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 2 quarters.
  • Sumitomo Mitsui Trust Group's Genomic Health, Inc. position peaked at $665K in Q4 2018.
  • 215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2019, filed 29 Jul 2019.